+220.6%
GLW vs CVS
+9.5%
+211.1%
-59.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.2% | -3.1% | +5.3% | +2.6% |
| 7D | -3.0% | -3.6% | +0.6% | -2.6% |
| 30D | -17.6% | -6.4% | -11.2% | -17.0% |
| 3M | -37.1% | -8.1% | -29.0% | -36.6% |
| 6M | -43.1% | -9.3% | -33.8% | -42.7% |
| YTD | +24.9% | +11.4% | +13.4% | +20.9% |
| 1Y | +34.9% | +12.8% | +22.1% | +30.3% |
| 3Y | +302.6% | +39.6% | +263.0% | +266.3% |
| 5Y | +220.6% | +9.4% | +211.2% | +224.4% |
| All | +220.6% | +9.5% | +211.1% | +224.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling